BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34358679)

  • 21. Assessment of the Relationship between Mortality and Troponin I Levels in Hospitalized Patients with the Novel Coronavirus (COVID-19).
    Özyılmaz S; Ergün Alış E; Ermiş E; Allahverdiyev S; Uçar H
    Medicina (Kaunas); 2020 Dec; 56(12):. PubMed ID: 33322097
    [No Abstract]   [Full Text] [Related]  

  • 22. Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study.
    Vidal-Cevallos P; Higuera-De-La-Tijera F; Chávez-Tapia NC; Sanchez-Giron F; Cerda-Reyes E; Rosales-Salyano VH; Servin-Caamaño A; Vázquez-Medina MU; Méndez-Sánchez N
    Ann Hepatol; 2021; 24():100338. PubMed ID: 33647501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac troponin I increase after successful percutaneous coronary angioplasty: predictors and long-term prognostic value.
    Okmen E; Cam N; Sanli A; Unal S; Tartan Z; Vural M
    Angiology; 2006; 57(2):161-9. PubMed ID: 16518523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients.
    Gunduz R; Yildiz BS; Ozdemir IH; Cetin N; Ozen MB; Bakir EO; Ozgur S; Bayturan O
    J Thromb Thrombolysis; 2021 Oct; 52(3):914-924. PubMed ID: 33730303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular outcomes for people hospitalised with COVID-19 in Australia, and the effect of vaccination: an observational cohort study.
    Sritharan HP; Bhatia KS; van Gaal W; Kritharides L; Chow CK; Bhindi R
    Med J Aust; 2024 Jun; 220(10):517-522. PubMed ID: 38741458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Troponin T in COVID-19 hospitalized patients: Kinetics matter.
    Luchian ML; Motoc AI; Lochy S; Magne J; Roosens B; Belsack D; Van den Bussche K; von Kemp B; Galloo X; François C; Scheirlynck E; Boeckstaens S; De Potter T; Seyler L; van Laethem J; Hennebicq S; Weytjens C; Droogmans S; Cosyns B
    Cardiol J; 2021; 28(6):807-815. PubMed ID: 34581431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry.
    Bhatt AS; Daniels LB; de Lemos J; Goodrich E; Bohula EA; Morrow DA;
    Am Heart J; 2023 Apr; 258():149-156. PubMed ID: 36669711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends.
    Tricoci P; Leonardi S; White J; White HD; Armstrong PW; Montalescot G; Giugliano RP; Gibson CM; Van de Werf F; Califf RM; Harrington RA; Braunwald E; Mahaffey KW; Newby LK
    J Am Coll Cardiol; 2013 Jul; 62(3):242-251. PubMed ID: 23684676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can a modified-simplified pulmonary embolism severity index (m-sPESI) be used to predict the need for intensive care in hospitalized COVID-19 patients?
    As AK; Erdolu B; Duman B; Yazgan E; Eris C; Aydin U; Ata Y; Sengoren Dikis O; Türk T
    J Thromb Thrombolysis; 2021 Oct; 52(3):759-765. PubMed ID: 33710508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac Troponin-I, A Biomarker for Predicting COVID-Induced Myocardial Damage Prognosis.
    Rehman A; Yousuf S; Maken GR; Naqvi SRA; Murtaza G; Ahmad A
    J Coll Physicians Surg Pak; 2023 May; 33(5):498-503. PubMed ID: 37190681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19.
    Deng F; Zhang L; Lyu L; Lu Z; Gao D; Ma X; Guo Y; Wang R; Gong S; Jiang W
    Med Clin (Barc); 2021 Apr; 156(7):324-331. PubMed ID: 33422296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of COVID-19 Patients With Troponin Elevation on Renal Impairment and Clinical Outcome.
    Case BC; Yerasi C; Forrestal BJ; Chezar-Azerrad C; Shea C; Rappaport H; Medranda GA; Zhang C; Satler LF; Ben-Dor I; Hashim H; Rogers T; Weintraub WS; Waksman R
    Cardiovasc Revasc Med; 2021 Dec; 33():45-48. PubMed ID: 34088598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
    Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
    J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal trends of COVID-19 related in-hospital mortality and demographics in Switzerland - a retrospective single centre cohort study.
    Diebold M; Martinez AE; Adam KM; Bassetti S; Osthoff M; Kassi E; Steiger J; Pargger H; Siegemund M; Battegay M; Khanna N; Schaub S; Wesch C; Dickenmann M; Weisser M
    Swiss Med Wkly; 2021 Jul; 151():w20572. PubMed ID: 34324697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic performance of preoperative cardiac troponin and perioperative changes in cardiac troponin for the prediction of major adverse cardiac events and mortality in noncardiac surgery: A systematic review and meta-analysis.
    Humble CAS; Huang S; Jammer I; Björk J; Chew MS
    PLoS One; 2019; 14(4):e0215094. PubMed ID: 31009468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rising Cardiac Troponin: A Prognostic Biomarker for Mortality After Acute Ischemic Stroke.
    Rosso M; Ramaswamy S; Mulatu Y; Little JN; Kvantaliani N; Brahmaroutu A; Marczak I; Lewey J; Deo R; Messé SR; Cucchiara BL; Levine SR; Kasner SE
    J Am Heart Assoc; 2024 Feb; 13(4):e032922. PubMed ID: 38348784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrepancy between biomarkers of lung injury and 1-year mortality in COVID-19.
    Atalay B; Cesur A; Agirbasli M
    Eur J Clin Invest; 2022 Sep; 52(9):e13827. PubMed ID: 35753029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact and Determinants of High-Sensitivity Cardiac Troponin-T Concentration in Patients With COVID-19 Admitted to Critical Care.
    Demir OM; Ryan M; Cirillo C; Desai N; Pericao A; Sinclair H; Stylianidis V; Victor K; Alaour B; Jones A; Pavlidis AN; Retter A; Carr-White G; Camporota L; Barrett N; Marber M; Perera D
    Am J Cardiol; 2021 May; 147():129-136. PubMed ID: 33617816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.